-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Relay Therapeutics, Inc. quarterly and annual Depreciation history and change rate from 2019 to Q1 2025.
- Relay Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $1,208,000, a 13.4% decline year-over-year.
- Relay Therapeutics, Inc. annual Depreciation for 2024 was $5,464,000, a 3.7% increase from 2023.
- Relay Therapeutics, Inc. annual Depreciation for 2023 was $5,269,000, a 27.6% increase from 2022.
- Relay Therapeutics, Inc. annual Depreciation for 2022 was $4,130,000, a 5.22% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)